Haruka Tsuchiya (H Tsuchiya)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Rheumatoid Arthritis

Interstitial Lung Disease

Systemic Lupus Erythematosus

Diffusion Weighted

Top Venues

Scandinavian journal of rheumatology

Rheumatology international

Annals of the rheumatic diseases

Modern rheumatology case reports

This page only lists publications with an associated author ORCID identifier.

Publications

R Yoshihara, Haruka Tsuchiya, Hirofumi Shoda, Keishi Fujio
Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease. Scandinavian journal of rheumatology (2024)
Hiroaki Harada, Hirofumi Shoda, Haruka Tsuchiya, Makoto Misaki, Takayuki Sawada, Keishi Fujio
Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease. Rheumatology international 44 (5) (2024)
Hiroaki Harada, Hirofumi Shoda, Haruka Tsuchiya, Makoto Misaki, Takayuki Sawada, Keishi Fujio
Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease. Rheumatology international 44 (5) (2024)
R Yoshihara, Haruka Tsuchiya, Hirofumi Shoda, Keishi Fujio
Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease. Scandinavian journal of rheumatology 53 (4) (2024)
Hiroaki Harada, Hirofumi Shoda, Haruka Tsuchiya, Makoto Misaki, Takayuki Sawada, Keishi Fujio
Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease. Rheumatology international 44 (5) (2024)
Hiroaki Harada, Hirofumi Shoda, Haruka Tsuchiya, Makoto Misaki, Takayuki Sawada, Keishi Fujio
Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease. Rheumatology international (2024)
Akihiro Kimura, Takeshi Takagi, Thiprampai Thamamongood, Satoshi Sakamoto, Takumi Ito, Iwao Seki, Masahiro Okamoto, Hiroyuki Aono, Satoshi Serada, Tetsuji Naka, Hiroaki Imataka, Kensuke Miyake, Takuya Ueda, Miki Miyanokoshi, Keisuke Wakasugi, Noriko Iwamoto, Norio Ohmagari, Takahiro Iguchi, Takeshi Nitta, Hiroshi Takayanagi, Hiroyuki Yamashita, Hiroshi Kaneko, Haruka Tsuchiya, Keishi Fujio, Hiroshi Handa, Harumi Suzuki
Extracellular aaRSs drive autoimmune and inflammatory responses in rheumatoid arthritis via the release of cytokines and PAD4. Annals of the rheumatic diseases (2023)
Toshihiko Komai, T Sawada, Haruka Tsuchiya, Hiroaki Harada, Hirofumi Shoda, Keishi Fujio
Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment. Scandinavian journal of rheumatology (2023)
Haruka Tsuchiya, Keishi Fujio
Emerging role of leptin in joint inflammation and destruction. Immunological medicine (2021)
Toshihiko Komai, Y Iwasaki, Y Tsuchida, N Hanata, Haruka Tsuchiya, Hiroaki Harada, Y Hamasaki, M Nangaku, H Shoda, K Fujio
Efficacy and safety of plasma exchange in interstitial lung diseases with anti-melanoma differentiation-associated 5 gene antibody positive clinically amyopathic dermatomyositis. Scandinavian journal of rheumatology (2021)
Haruka Tsuchiya, Yukiko Iwasaki, Hirofumi Shoda, Yukitoshi Takahashi, Keishi Fujio
Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies. Modern rheumatology case reports 5 (2) (2021)
Haruka Tsuchiya, Norio Hanata, Hiroaki Harada, Hirofumi Shoda, Keishi Fujio
Intestinal ulcers induced by intravesical bacillus Calmette-Guérin therapy. Modern rheumatology case reports 5 (2) (2021)
Haruka Tsuchiya, Mineto Ota, Shuji Sumitomo, Kazuyoshi Ishigaki, Akari Suzuki, Toyonori Sakata, Yumi Tsuchida, Hiroshi Inui, Jun Hirose, Yuta Kochi, Yuho Kadono, Katsuhiko Shirahige, Sakae Tanaka, Kazuhiko Yamamoto, Keishi Fujio
Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis. Annals of the rheumatic diseases (2020)